Inventor
AYMERIC LEVEAU
Inventor
FR
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes29%
A61KPreparations for medical, dental or toiletry purposes18%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
C07KPeptides18%
C40BCombinatorial chemistry18%
PatentTitleYear
12,460,216Phage-derived particles for in situ delivery of DNA payload into C. acnes population202512,454,696None202511,970,701Phage-derived particles for in situ delivery of DNA payload into 202411,952,595Production of lytic phages202411,939,598Production bacterial cells and use thereof in production methods202411,840,695Recombinant 202311,820,989Phage-derived particles for in situ delivery of DNA payload into 202311,739,304Production of lytic phages202311,697,802Production bacterial cells and use thereof in production methods202311,473,093None2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to ELIGO BIOSCIENCE (10)· patent assignee history
2022–2025Based in FR· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ELIGO BIOSCIENCE | 10 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| FR | 10 | 2022–2025 |